CUTIVATE ong tb 30 g

7680523810015 CH-52381 D07AC17 10.05.1.
CUTIVATE ong tb 30 g
CUTIVATE ong tb 30 g
CUTIVATE ong tb 30 g
1 / 3
google

Details

Product number
5238101
CPT
-
Packaging group
30
Unit
g
Composition
fluticasoni propionas 50 µg, propylenglycolum, excipiens ad unguentum pro 1 g.

Articles (1)

Cutivate, Salbe
Salbe
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Professional SmPC
Allemand
27/06/2025
Professional SmPC
Français
27/06/2025
Professional SmPC
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
sorbitani sesquioleas
- Substance HNIDK
paraffinum microcristallinum
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
paraffinum liquidum
- Substance HNIDK

Reimbursement information

Public price
CHF 13.25
Specialties list
Yes
Generic
No
SL addition date: 01/04/2016

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
52381
Drug name
Cutivate, Salbe
Galenic form
SALB
ATC Code
D07AC17
Authorization status
Z
Dispensation category
B
First authorization
13/06/1994
Authorization expiration date
31/12/9999
IT number
10.05.1.
Domain
Human medicine
Field of application
Entzündliche, nicht infizierte Dermatosen

Packaging details

Description (FR)
CUTIVATE ong tb 30 g
Description (DE)
CUTIVATE Salbe Tb 30 g
Market launch
13/06/1994
Narcotic (BTM)
No

Other packaging sizes